A common virus may be a major cause of high blood pressure, researchers said on Thursday in a finding that may bring new approach to treating a condition that affects an estimated 1 billion people worldwide.
Crumpacker said the study suggests vaccines and antiviral drugs may offer a new approach at treating hypertension.
Currently, there is no vaccine, but several companies, including Sanofi-Aventis, Novartis , GlaxoSmithKline PLC and Vical, are working on them.
And Swiss drugmaker Roche Holding AG makes an antiviral drug called Valcyte to prevent CMV infections in transplant recipients.
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.